Literature DB >> 4784889

Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage.

M Thelestam, R Möllby, T Wadström.   

Abstract

Human diploid embryonic lung fibroblasts and HeLa cells were cultivated in Eagle minimaĺ essential medium supplemented with 10% calf serum. Monolayer cultures were labeled with (3)H-uridine and treated with highly purified staphylococcal alpha-, beta-, delta-, or gamma-hemolysin. The release of soluble radioactive substances into the medium was used as an indicator of damage to the cell membrane after treatment with each hemolysin. The assay method described is simple, sensitive, and rapid. It allows quantitative estimation of changes in membrane permeability to be detected before a morphological damage is observed microscopically. Upon incubation for up to 30 min with highly purified staphylococcal hemolysins, only delta-hemolysin caused release of a significant amount of tritiated substances from fibroblasts. Such leakage occurred immediately after addition of delta-lysin and was independent of temperature. With minor exceptions, this was similar to the release of isotopes after treatment of the cells with the nonionic detergent Triton X-100. Treatment of fibroblasts with combinations of two or three of these toxins gave neither a synergistic nor an antagonistic effect. Evidence is presented which indicates that delta-hemolysin is the only important fibroblast damaging activity in crude preparations of extracellular proteins of four strains of S. aureus, whereas HeLa cells are susceptible also to purified alpha-toxin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4784889      PMCID: PMC422954          DOI: 10.1128/iai.8.6.938-946.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.

Authors:  R Möllby; C E Nord; T Wadström
Journal:  Toxicon       Date:  1973-02       Impact factor: 3.033

2.  The cytopathic action of purified staphylococcal delta-hemolysin.

Authors:  G P Gladstone; A Yoshida
Journal:  Br J Exp Pathol       Date:  1967-02

3.  Topography of membrane concanavalin A sites modified by proteolysis.

Authors:  G L Nicolson
Journal:  Nat New Biol       Date:  1972-10-18

4.  Human diploid cell response to variations in relative amino acid concentrations in Eagle medium.

Authors:  J Litwin
Journal:  Exp Cell Res       Date:  1972-06       Impact factor: 3.905

5.  Interference by trypsin in the interaction of staphylococcal enterotoxin B and cell cultures of human embryonic intestine.

Authors:  W I Schaeffer; J Gabliks; R Calitis
Journal:  J Bacteriol       Date:  1967-05       Impact factor: 3.490

6.  The nature of staphylococcal beta hemolysin. II. Effect on mammalian cells.

Authors:  G M Wiseman
Journal:  Can J Microbiol       Date:  1968-02       Impact factor: 2.419

7.  Studies on extracellular proteins from Staphylococcus aureus. IV. Separation of alpha-toxin by isoelectric focusing.

Authors:  T Wadström
Journal:  Biochim Biophys Acta       Date:  1968-10-21

8.  The effect of commercial and pure gentamicin on the growth of human diploid lung fibroblasts.

Authors:  J Litwin
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

9.  Standardization of human diploid fibroblast cultivation: centrifugation procedure.

Authors:  J Litwin
Journal:  Appl Microbiol       Date:  1971-04

10.  Staphylococcal delta hemolysin: purification and characterization.

Authors:  H S Kantor; B Temples; W V Shaw
Journal:  Arch Biochem Biophys       Date:  1972-07       Impact factor: 4.013

View more
  30 in total

Review 1.  The hemolysins of Staphylococcus aureus.

Authors:  G M Wiseman
Journal:  Bacteriol Rev       Date:  1975-12

2.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 3.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

4.  Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts.

Authors:  M Thelestam; R Möllby
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  Determination of toxin-induced leakage of different-size nucleotides through the plasma membrane of human diploid fibroblasts.

Authors:  M Thelestam; R Möllby
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 6.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

7.  Quantitative analysis of the binding and oligomerization of staphylococcal alpha-toxin in target erythrocyte membranes.

Authors:  J Reichwein; F Hugo; M Roth; A Sinner; S Bhakdi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

8.  Distribution of 3H-labeled staphylococcal alpha-toxin and a toxin fragment in mice.

Authors:  L Blomqvist; L E Appelgren; M Thelestam
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  Quantitation of monomeric and oligomeric forms of membrane-bound staphylococcal alpha-toxin by enzyme-linked immunosorbent assay with a neutralizing monoclonal antibody.

Authors:  F Hugo; A Sinner; J Reichwein; S Bhakdi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

10.  Early events in the action of staphylococcal alpha-toxin on the plasma membrane of adrenocortical Y1 tumor cells.

Authors:  L Blomqvist; M Thelestam
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.